Douglas Rehder

Title: The Innovative Contributions of Douglas Rehder

Introduction

Douglas Rehder is a notable inventor based in Phoenix, AZ, who has made significant contributions to the field of biospecimen analysis and disease monitoring. With a total of 7 patents to his name, Rehder's work focuses on advancing methods for analyzing glycan-derived monosaccharides and assessing biospecimen integrity.

Latest Patents

Rehder's latest patents include innovative methods for analyzing glycan-derived monosaccharides in a sample. This disclosure provides a method for detecting or monitoring diseases or disorders in patients. Additionally, it offers a method for determining aberrant glycotransferase activity and a system for analyzing or comparing glycates in a sample. Another significant patent involves methods for quantifying biospecimen sample integrity using markers of oxidation. This method addresses the spontaneous oxidation that occurs under conditions of incomplete blood plasma or serum sample freezing. The oxidative chemistries of specific markers are crucial for assessing biospecimen integrity.

Career Highlights

Throughout his career, Douglas Rehder has worked with prominent organizations such as Amgen Inc. and Arizona State University. His experience in these institutions has allowed him to develop and refine his innovative methodologies, contributing to advancements in medical research and diagnostics.

Collaborations

Rehder has collaborated with notable colleagues, including Pavel V Bondarenko and Chad Borges. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Douglas Rehder's contributions to innovation in biospecimen analysis and disease monitoring exemplify the impact of dedicated inventors in advancing medical science. His patents and collaborations reflect a commitment to improving healthcare through innovative solutions.